 | • レポートコード：MRC2-11QY03859 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はムーコル症のグローバル市場について調査・分析したレポートです。種類別（手術、抗真菌薬、アムホテリシンB療法）市場規模、用途別（病院・診療所、医療機関、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ムーコル症の競争状況、市場シェア ・世界のムーコル症市場：種類別市場規模 2015年-2020年（手術、抗真菌薬、アムホテリシンB療法） ・世界のムーコル症市場：種類別市場規模予測 2021年-2026年（手術、抗真菌薬、アムホテリシンB療法） ・世界のムーコル症市場：用途別市場規模 2015年-2020年（病院・診療所、医療機関、研究機関） ・世界のムーコル症市場：用途別市場規模予測 2021年-2026年（病院・診療所、医療機関、研究機関） ・北米のムーコル症市場分析：米国、カナダ ・ヨーロッパのムーコル症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのムーコル症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のムーコル症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのムーコル症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Biocon、Cadila Pharmaceuticals、Novartis、Merck、Roche、Bristol Myers Squibb、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Mucormycosis is any fungal infection caused by fungi in the order Mucorales. Generally, species in the Mucor, Rhizopus, Absidia, and Cunninghamella genera are most often implicated. The disease is often characterized by hyphae growing in and around blood vessels and can be potentially life-threatening in diabetic or severely immunocompromised individuals.
If mucormycosis is suspected, amphotericin B therapy should be immediately administered due to the rapid spread and high mortality rate of the disease. Amphotericin B is usually administered for an additional 4–6 weeks after initial therapy begins to ensure eradication of the infection. After administration of either amphotericin B or posaconazole, surgical removal of the “fungus ball” is indicated. The disease must be monitored carefully for any signs of reemergence.
Market Analysis and Insights: Global Mucormycosis Market
The global Mucormycosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Mucormycosis Scope and Market Size
Mucormycosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mucormycosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Biocon
Cadila Pharmaceuticals
Novartis
Merck
Roche
Bristol Myers Squibb
Pfizer
Market segment by Type, the product can be split into
Surgery
Antifungal Drugs
Amphotericin B Therapy
Market segment by Application, split into
Hospitals & Clinics
Medical Institutes
Research Organization
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mucormycosis Revenue
1.4 Market by Type
1.4.1 Global Mucormycosis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Antifungal Drugs
1.4.4 Amphotericin B Therapy
1.5 Market by Application
1.5.1 Global Mucormycosis Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Medical Institutes
1.5.4 Research Organization
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Mucormycosis Market Perspective (2015-2026)
2.2 Global Mucormycosis Growth Trends by Regions
2.2.1 Mucormycosis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Mucormycosis Historic Market Share by Regions (2015-2020)
2.2.3 Mucormycosis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Mucormycosis Market Growth Strategy
2.3.6 Primary Interviews with Key Mucormycosis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Mucormycosis Players by Market Size
3.1.1 Global Top Mucormycosis Players by Revenue (2015-2020)
3.1.2 Global Mucormycosis Revenue Market Share by Players (2015-2020)
3.1.3 Global Mucormycosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mucormycosis Market Concentration Ratio
3.2.1 Global Mucormycosis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Mucormycosis Revenue in 2019
3.3 Mucormycosis Key Players Head office and Area Served
3.4 Key Players Mucormycosis Product Solution and Service
3.5 Date of Enter into Mucormycosis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Mucormycosis Historic Market Size by Type (2015-2020)
4.2 Global Mucormycosis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Mucormycosis Market Size by Application (2015-2020)
5.2 Global Mucormycosis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Mucormycosis Market Size (2015-2020)
6.2 Mucormycosis Key Players in North America (2019-2020)
6.3 North America Mucormycosis Market Size by Type (2015-2020)
6.4 North America Mucormycosis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Mucormycosis Market Size (2015-2020)
7.2 Mucormycosis Key Players in Europe (2019-2020)
7.3 Europe Mucormycosis Market Size by Type (2015-2020)
7.4 Europe Mucormycosis Market Size by Application (2015-2020)
8 China
8.1 China Mucormycosis Market Size (2015-2020)
8.2 Mucormycosis Key Players in China (2019-2020)
8.3 China Mucormycosis Market Size by Type (2015-2020)
8.4 China Mucormycosis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Mucormycosis Market Size (2015-2020)
9.2 Mucormycosis Key Players in Japan (2019-2020)
9.3 Japan Mucormycosis Market Size by Type (2015-2020)
9.4 Japan Mucormycosis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Mucormycosis Market Size (2015-2020)
10.2 Mucormycosis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mucormycosis Market Size by Type (2015-2020)
10.4 Southeast Asia Mucormycosis Market Size by Application (2015-2020)
11 India
11.1 India Mucormycosis Market Size (2015-2020)
11.2 Mucormycosis Key Players in India (2019-2020)
11.3 India Mucormycosis Market Size by Type (2015-2020)
11.4 India Mucormycosis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Mucormycosis Market Size (2015-2020)
12.2 Mucormycosis Key Players in Central & South America (2019-2020)
12.3 Central & South America Mucormycosis Market Size by Type (2015-2020)
12.4 Central & South America Mucormycosis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Mucormycosis Introduction
13.1.4 Abbott Laboratories Revenue in Mucormycosis Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Biocon
13.2.1 Biocon Company Details
13.2.2 Biocon Business Overview
13.2.3 Biocon Mucormycosis Introduction
13.2.4 Biocon Revenue in Mucormycosis Business (2015-2020)
13.2.5 Biocon Recent Development
13.3 Cadila Pharmaceuticals
13.3.1 Cadila Pharmaceuticals Company Details
13.3.2 Cadila Pharmaceuticals Business Overview
13.3.3 Cadila Pharmaceuticals Mucormycosis Introduction
13.3.4 Cadila Pharmaceuticals Revenue in Mucormycosis Business (2015-2020)
13.3.5 Cadila Pharmaceuticals Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Mucormycosis Introduction
13.4.4 Novartis Revenue in Mucormycosis Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Mucormycosis Introduction
13.5.4 Merck Revenue in Mucormycosis Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Mucormycosis Introduction
13.6.4 Roche Revenue in Mucormycosis Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Bristol Myers Squibb
13.7.1 Bristol Myers Squibb Company Details
13.7.2 Bristol Myers Squibb Business Overview
13.7.3 Bristol Myers Squibb Mucormycosis Introduction
13.7.4 Bristol Myers Squibb Revenue in Mucormycosis Business (2015-2020)
13.7.5 Bristol Myers Squibb Recent Development
13.8 Pfizer
13.8.1 Pfizer Company Details
13.8.2 Pfizer Business Overview
13.8.3 Pfizer Mucormycosis Introduction
13.8.4 Pfizer Revenue in Mucormycosis Business (2015-2020)
13.8.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Mucormycosis Key Market Segments
Table 2. Key Players Covered: Ranking by Mucormycosis Revenue
Table 3. Ranking of Global Top Mucormycosis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Mucormycosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Antifungal Drugs
Table 7. Key Players of Amphotericin B Therapy
Table 8. Global Mucormycosis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Mucormycosis Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Mucormycosis Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Mucormycosis Market Share by Regions (2015-2020)
Table 12. Global Mucormycosis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Mucormycosis Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Mucormycosis Market Growth Strategy
Table 18. Main Points Interviewed from Key Mucormycosis Players
Table 19. Global Mucormycosis Revenue by Players (2015-2020) (Million US$)
Table 20. Global Mucormycosis Market Share by Players (2015-2020)
Table 21. Global Top Mucormycosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucormycosis as of 2019)
Table 22. Global Mucormycosis by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Mucormycosis Product Solution and Service
Table 25. Date of Enter into Mucormycosis Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Mucormycosis Market Size by Type (2015-2020) (Million US$)
Table 28. Global Mucormycosis Market Size Share by Type (2015-2020)
Table 29. Global Mucormycosis Revenue Market Share by Type (2021-2026)
Table 30. Global Mucormycosis Market Size Share by Application (2015-2020)
Table 31. Global Mucormycosis Market Size by Application (2015-2020) (Million US$)
Table 32. Global Mucormycosis Market Size Share by Application (2021-2026)
Table 33. North America Key Players Mucormycosis Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Mucormycosis Market Share (2019-2020)
Table 35. North America Mucormycosis Market Size by Type (2015-2020) (Million US$)
Table 36. North America Mucormycosis Market Share by Type (2015-2020)
Table 37. North America Mucormycosis Market Size by Application (2015-2020) (Million US$)
Table 38. North America Mucormycosis Market Share by Application (2015-2020)
Table 39. Europe Key Players Mucormycosis Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Mucormycosis Market Share (2019-2020)
Table 41. Europe Mucormycosis Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Mucormycosis Market Share by Type (2015-2020)
Table 43. Europe Mucormycosis Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Mucormycosis Market Share by Application (2015-2020)
Table 45. China Key Players Mucormycosis Revenue (2019-2020) (Million US$)
Table 46. China Key Players Mucormycosis Market Share (2019-2020)
Table 47. China Mucormycosis Market Size by Type (2015-2020) (Million US$)
Table 48. China Mucormycosis Market Share by Type (2015-2020)
Table 49. China Mucormycosis Market Size by Application (2015-2020) (Million US$)
Table 50. China Mucormycosis Market Share by Application (2015-2020)
Table 51. Japan Key Players Mucormycosis Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Mucormycosis Market Share (2019-2020)
Table 53. Japan Mucormycosis Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Mucormycosis Market Share by Type (2015-2020)
Table 55. Japan Mucormycosis Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Mucormycosis Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Mucormycosis Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Mucormycosis Market Share (2019-2020)
Table 59. Southeast Asia Mucormycosis Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Mucormycosis Market Share by Type (2015-2020)
Table 61. Southeast Asia Mucormycosis Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Mucormycosis Market Share by Application (2015-2020)
Table 63. India Key Players Mucormycosis Revenue (2019-2020) (Million US$)
Table 64. India Key Players Mucormycosis Market Share (2019-2020)
Table 65. India Mucormycosis Market Size by Type (2015-2020) (Million US$)
Table 66. India Mucormycosis Market Share by Type (2015-2020)
Table 67. India Mucormycosis Market Size by Application (2015-2020) (Million US$)
Table 68. India Mucormycosis Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Mucormycosis Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Mucormycosis Market Share (2019-2020)
Table 71. Central & South America Mucormycosis Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Mucormycosis Market Share by Type (2015-2020)
Table 73. Central & South America Mucormycosis Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Mucormycosis Market Share by Application (2015-2020)
Table 75. Abbott Laboratories Company Details
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Product
Table 78. Abbott Laboratories Revenue in Mucormycosis Business (2015-2020) (Million US$)
Table 79. Abbott Laboratories Recent Development
Table 80. Biocon Company Details
Table 81. Biocon Business Overview
Table 82. Biocon Product
Table 83. Biocon Revenue in Mucormycosis Business (2015-2020) (Million US$)
Table 84. Biocon Recent Development
Table 85. Cadila Pharmaceuticals Company Details
Table 86. Cadila Pharmaceuticals Business Overview
Table 87. Cadila Pharmaceuticals Product
Table 88. Cadila Pharmaceuticals Revenue in Mucormycosis Business (2015-2020) (Million US$)
Table 89. Cadila Pharmaceuticals Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Mucormycosis Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Product
Table 98. Merck Revenue in Mucormycosis Business (2015-2020) (Million US$)
Table 99. Merck Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche Product
Table 103. Roche Revenue in Mucormycosis Business (2015-2020) (Million US$)
Table 104. Roche Recent Development
Table 105. Bristol Myers Squibb Company Details
Table 106. Bristol Myers Squibb Business Overview
Table 107. Bristol Myers Squibb Product
Table 108. Bristol Myers Squibb Revenue in Mucormycosis Business (2015-2020) (Million US$)
Table 109. Bristol Myers Squibb Recent Development
Table 110. Pfizer Business Overview
Table 111. Pfizer Product
Table 112. Pfizer Company Details
Table 113. Pfizer Revenue in Mucormycosis Business (2015-2020) (Million US$)
Table 114. Pfizer Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mucormycosis Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Antifungal Drugs Features
Figure 4. Amphotericin B Therapy Features
Figure 5. Global Mucormycosis Market Share by Application: 2020 VS 2026
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Medical Institutes Case Studies
Figure 8. Research Organization Case Studies
Figure 9. Mucormycosis Report Years Considered
Figure 10. Global Mucormycosis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Mucormycosis Market Share by Regions: 2020 VS 2026
Figure 12. Global Mucormycosis Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Mucormycosis Market Share by Players in 2019
Figure 15. Global Top Mucormycosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucormycosis as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Mucormycosis Revenue in 2019
Figure 17. North America Mucormycosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Mucormycosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Mucormycosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Mucormycosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Mucormycosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Mucormycosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Mucormycosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
心臓手術・装置・薬剤の世界市場（～2026年） Cardiology is a branch of medicine dealing with disorders of the heart as well as parts of the circulatory system. One of the major factors driving the market is medical tourism. Market Analysis and Insights: Global Cardiology Surgery, Devices and Drugs Market The global Cardiology Surgery, Devices …- 画期的治療薬の世界市場（～2026年） Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two f…
- 成形外科の世界市場（～2026年） Plastic surgery is a surgical specialty involving the restoration, reconstruction or alteration of the human body. Plastic surgery can be divided into two categories. The first is reconstructive surgery which includes craniofacial surgery, hand surgery, microsurgery and the treatment of burns. The o…
- 抗真菌薬の世界市場（～2026年） Novartis AG (Switzerland), Pfizer Inc. (U.S), Sanofi (France), Merck & Co., Inc. (U.S), Astellas (Japan), Bayer AG (Germany) Increasing prevalence of HIV in Asia Pacific region is the key factor for the market growth. Rising awareness about the antifungal treatment and availability of new treatment …
- 婦人科ロボット手術の世界市場（～2026年） Gynecological surgery robots are robotic systems that are used to perform gynecological surgeries. There has been an emergence of novel product offerings in the market, which facilitate robotic and computer-assisted gynecology surgeries. Such products are gaining traction due to the increase in the …